AUSTIN, 20 APRIL 2026: OriGen Biomedical, a leading provider of cryopreservation and cell culture products, today announced that President and CEO Beth San Segundo has been featured in the Austin Business Journal in a profile by staff writer Cody Baird. The article highlights OriGen’s upcoming headquarters relocation and significant expansion in Austin, as well as the company’s continued growth in the advanced therapy space.
The article spotlights OriGen’s evolution as an Austin-based medical device manufacturer and its role in supporting the rapidly advancing field of cell and gene therapy. It also highlights the company’s investment in a new headquarters and expanded manufacturing capabilities, positioning OriGen for continued scale and innovation.
Founded in 1997, OriGen Biomedical develops single-use technologies used in the collection, storage, processing, and cryopreservation of cellular material for advanced therapies. The company’s focus on user-informed design and close collaboration with clinicians and laboratories has helped establish it as a trusted partner in the life sciences industry.
“It’s an exciting time for OriGen as we continue to grow in Austin and expand our capabilities,” said Beth San Segundo, President and CEO of OriGen Biomedical. “We’re proud to be part of a community that supports innovation and to contribute to advancements that ultimately improve patient outcomes.”
The Austin Business Journal feature also touches on OriGen’s ongoing facility expansion and the role of Bank of America in supporting the company’s growth. Together, these efforts reflect OriGen’s long-term commitment to scaling its operations while maintaining high-quality standards and supporting the needs of its global customer base.
OriGen currently employs nearly 200 professionals in the Austin area across engineering, manufacturing, and life sciences roles, with continued opportunities for growth as the company expands its footprint.
ABOUT ORIGEN BIOMEDICAL
OriGen Biomedical, Inc. is a leading producer of cryopreservation and cell culture products. Our focus is to produce a range of products to support the treatment of cancer, genetic conditions, and other life-threatening diseases. OriGen Biomedical® products are designed with the patient and user in mind, and we strive to maintain excellent customer service to ensure that patient care is the priority. Quality is the foundation of all product designs at OriGen, and each product is produced with the intention that it will improve patient health. Founded in 1997 and headquartered in Austin, Texas, OriGen is certified annually to ISO 13485 standards and regularly inspected by the FDA, MDSAP, ISO certification organizations, and our customers. To learn more visit www.origen.com and follow us on LinkedIn and X.
CONTACT:
Kirsten Krupps – Senior Marketing Manager
OriGen Biomedical, Inc.
k.krupps@origenbio.com
512-474-7278
